Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPROPION Cause Suspected product quality issue? 10 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Suspected product quality issue have been filed in association with BUPROPION (Bupropion Hydrochloride (XL)). This represents 0.0% of all adverse event reports for BUPROPION.

10
Reports of Suspected product quality issue with BUPROPION
0.0%
of all BUPROPION reports
0
Deaths
0
Hospitalizations

How Dangerous Is Suspected product quality issue From BUPROPION?

Of the 10 reports.

Is Suspected product quality issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPROPION. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does BUPROPION Cause?

Completed suicide (5,095) Drug ineffective (3,991) Toxicity to various agents (3,837) Depression (2,486) Overdose (2,357) Headache (2,323) Anxiety (2,145) Intentional overdose (2,103) Drug hypersensitivity (1,967) Seizure (1,894)

What Other Drugs Cause Suspected product quality issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (64) LEVOTHYROXINE (37) HUMAN IMMUNOGLOBULIN G (32) ESTRADIOL (30) ONABOTULINUMTOXINA (30) SODIUM (30) CLONAZEPAM (29) AFLIBERCEPT (27) INSULIN GLARGINE (27) IOPROMIDE (25)

Which BUPROPION Alternatives Have Lower Suspected product quality issue Risk?

BUPROPION vs BUPROPION HYDROBROMIDE BUPROPION vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE BUPROPION vs BUPROPION\NALTREXONE BUPROPION vs BUROSUMAB BUPROPION vs BUROSUMAB-TWZA

Related Pages

BUPROPION Full Profile All Suspected product quality issue Reports All Drugs Causing Suspected product quality issue BUPROPION Demographics